![Leah Monteiro](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Leah Monteiro worked as Senior Director-Communications & IR at KalVista Pharmaceuticals, Inc. from 2016 to 2021.
The career history includes roles as Vice President-Investor Relations at DURECT Corp., Senior Manager-Investor Relations at Genzyme Corp., Manager-Corporate Communications at Sesen Bio, Inc., and Vice President-Investor Relations & Communications at Solid Biosciences, Inc. from 2023 to 2024.
Former jobs include positions at KalVista Pharmaceuticals, Inc., DURECT Corp., Genzyme Corp., Sesen Bio, Inc., and Solid Biosciences, Inc.
Tidigare kända positioner av Leah Monteiro
| Företag | Position | Slut |
|---|---|---|
| SOLID BIOSCIENCES INC. | Investor Relations Kontakt | 2024-04-30 |
| KALVISTA PHARMA | Investor Relations Kontakt | 2021-12-01 |
| CARISMA THERAPEUTICS, INC. | Investor Relations Kontakt | 2016-07-01 |
| DURECT | Investor Relations Kontakt | - |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Investor Relations Kontakt | - |
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
16
Första gradens relationer
5
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 5 |
|---|---|
DURECT Corp.
 DURECT Corp. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for pain and chronic diseases | Health Technology |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Sesen Bio, Inc.
 Sesen Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops protein therapeutics to treat eye diseases | Health Technology |
Solid Biosciences, Inc.
 Solid Biosciences, Inc. BiotechnologyHealth Technology Operates as a pharmaceutical company that develops treatments through gene therapy for patients with duchenne disease | Health Technology |
KalVista Pharmaceuticals, Inc.
 KalVista Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets small molecule protease inhibitors for diseases | Health Technology |
